Botanical/Drug Interaction Studies Should Be Based On Safety Risk - CHPA

"Extensive" investigation of drug-drug interactions for botanical drug products is not necessary unless a safety risk is indicated by adverse event reports or other animal or clinical data, the Consumer Healthcare Products Association asserts.